Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11971)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 28, 2017 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Taherkhani R, Farshadpour F. Global elimination of hepatitis C virus infection: Progresses and the remaining challenges. World J Hepatol 2017; 9(33): 1239-1252 [PMID: 29312527 DOI: 10.4254/wjh.v9.i33.1239] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i33/1239.htm |
| Number | Citing Articles |
| 1 |
Nicole Brenner, Alexander J. Mentzer, Julia Butt, Kathrin L. Braband, Angelika Michel, Katie Jeffery, Paul Klenerman, Barbara Gärtner, Paul Schnitzler, Adrian Hill, Graham Taylor, Maria A. Demontis, Edward Guy, Stephen J. Hadfield, Rachael Almond, Naomi Allen, Michael Pawlita, Tim Waterboer, Isabelle Chemin. Validation of Multiplex Serology for human hepatitis viruses B and C, human T-lymphotropic virus 1 and Toxoplasma gondii. PLOS ONE 2019; 14(1): e0210407 doi: 10.1371/journal.pone.0210407
|
| 2 |
Nativa Helena Alves Del‐Rios, Lyriane Apolinário de Araujo, Regina Maria Bringel Martins, Rafael Alves Guimarães, Márcia Alves Dias de Matos, Karlla Antonieta Amorim Caetano, Raquel Silva Pinheiro, Divânia Dias da Silva França, Leandro Nascimento da Silva, Sheila Araújo Teles, Megmar Aparecida dos Santos Carneiro. Molecular and epidemiological aspects of hepatitis C virus infection among crack cocaine users. Journal of Medical Virology 2020; 92(8): 1239 doi: 10.1002/jmv.25632
|
| 3 |
Rehab I Moustafa, Jean Dubuisson, Muriel Lavie. Function of the HCV E1 Envelope Glycoprotein in Viral Entry and Assembly. Future Virology 2019; 14(3): 171 doi: 10.2217/fvl-2018-0180
|
| 4 |
Fareed Ghulam, Noval Zakaria, Muhammad Ibrahim Majeed, Faisal Ismail. Viral Hepatitis - The Road Traveled and the Journey Remaining. Hepatic Medicine: Evidence and Research 2022; : 13 doi: 10.2147/HMER.S352568
|
| 5 |
Ghirmay Ghebrekidan Ghebremeskel, Michael Berhe Solomon, Oliver Okoth Achila, Samuel Tekle Mengistu, Rahel Frezghi Asmelash, Araia Berhane Mesfin, Mohammed Elfatih Hamida. Real-world treatment outcome of direct-acting antivirals and patient survival rates in chronic hepatitis C virus infection in Eritrea. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-47258-7
|
| 6 |
Shahab Mahmoudvand, Somayeh Shokri, Reza Taherkhani, Fatemeh Farshadpour. Hepatitis C virus core protein modulates several signaling pathways involved in hepatocellular carcinoma. World Journal of Gastroenterology 2019; 25(1): 42-58 doi: 10.3748/wjg.v25.i1.42
|
| 7 |
Nour Mammari, Ysaline Krier, Quentin Albert, Marc Devocelle, Mihayl Varbanov. Plant-Derived Antimicrobial Peptides as Potential Antiviral Agents in Systemic Viral Infections. Pharmaceuticals 2021; 14(8): 774 doi: 10.3390/ph14080774
|
| 8 |
Vadim A. Shiryaev, Eugene V. Radchenko, Vladimir A. Palyulin, Nikolay S. Zefirov, Nikolay I. Bormotov, Olga A. Serova, Larisa N. Shishkina, Marat R. Baimuratov, Kseniya M. Bormasheva, Yulia A. Gruzd, Elena A. Ivleva, Marina V. Leonova, Anton V. Lukashenko, Dmitry V. Osipov, Vitaliy A. Osyanin, Alexander N. Reznikov, Vera A. Shadrikova, Anastasia E. Sibiryakova, Ilya M. Tkachenko, Yuri N. Klimochkin. Molecular design, synthesis and biological evaluation of cage compound-based inhibitors of hepatitis C virus p7 ion channels. European Journal of Medicinal Chemistry 2018; 158: 214 doi: 10.1016/j.ejmech.2018.08.009
|
| 9 |
Fatemeh Farshadpour, Reza Taherkhani, Farkhondeh Bakhtiari, Haruki Komatsu. Prevalence and Predominant Genotype of Hepatitis C Virus Infection and Associated Risk Factors among Pregnant Women in Iran. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/9294276
|
| 10 |
J Sira, M Brown, S Ambegaokar, L Modin, DA Kelly. The necessity of education and hepatitis B vaccination for young people: A study of high risk behaviour for blood borne viruses in the United Kingdom. Journal of Child Health Care 2019; 23(3): 437 doi: 10.1177/1367493519831499
|
| 11 |
Rehab I. Moustafa, Juliano G. Haddad, Lydia Linna, Xavier Hanoulle, Véronique Descamps, Ahmed Atef Mesalam, Thomas F. Baumert, Gilles Duverlie, Philip Meuleman, Jean Dubuisson, Muriel Lavie, J.-H. James Ou. Functional Study of the C-Terminal Part of the Hepatitis C Virus E1 Ectodomain. Journal of Virology 2018; 92(20) doi: 10.1128/JVI.00939-18
|
| 12 |
Malik Sallam, Roaa Khalil. Contemporary Insights into Hepatitis C Virus: A Comprehensive Review. Microorganisms 2024; 12(6): 1035 doi: 10.3390/microorganisms12061035
|
| 13 |
Luis Antonio Uribe‐Noguez, Alicia Ocaña‐Mondragón, José Antonio Mata‐Marín, María Elena Gómez‐Torres, Rosa María Ribas‐Aparicio, María de la Luz Martínez‐Rodríguez. Presence of rare hepatitis C virus subtypes, 2j, 2k, and 2r in Mexico City as identified by sequencing. Journal of Medical Virology 2018; 90(7): 1277 doi: 10.1002/jmv.25070
|
| 14 |
Yanpeng Li, Le Cao, Mei Ye, Rong Xu, Xin Chen, Yingying Ma, Ren-Rong Tian, Feng-Liang Liu, Peng Zhang, Yi-Qun Kuang, Yong-Tang Zheng, Chiyu Zhang, Alison Sinclair. Plasma Virome Reveals Blooms and Transmission of Anellovirus in Intravenous Drug Users with HIV-1, HCV, and/or HBV Infections. Microbiology Spectrum 2022; 10(4) doi: 10.1128/spectrum.01447-22
|
| 15 |
Bridget Williams, Jessica Howell, Joseph Doyle, Alexander J. Thompson, Bridget Draper, Chloe Layton, Ned Latham, Frances Bramwell, Dean Membrey, Maggie Mcpherson, Janine Roney, Mark Stoové, Margaret E. Hellard, Alisa Pedrana. Point-of-care hepatitis C testing from needle and syringe programs: An Australian feasibility study. International Journal of Drug Policy 2019; 72: 91 doi: 10.1016/j.drugpo.2019.05.012
|
| 16 |
Melanie R. Walker, Preston Leung, Auda A. Eltahla, Alexander Underwood, Arunasingam Abayasingam, Nicholas A. Brasher, Hui Li, Bing-Ru Wu, Lisa Maher, Fabio Luciani, Andrew R. Lloyd, Rowena A. Bull. Clearance of hepatitis C virus is associated with early and potent but narrowly-directed, Envelope-specific antibodies. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-49454-w
|
| 17 |
Carolina Coutinho, Leonardo S. Bastos, Jurema Corrêa da Mota, Lidiane Toledo, Katia Costa, Neilane Bertoni, Francisco I. Bastos. The risks of HCV infection among Brazilian crack cocaine users: incorporating diagnostic test uncertainty. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-018-35657-0
|
| 18 |
Hoda El Aggan, Nahla Farahat, Nevine El Deeb, Ahmed Zeid, Assem El-Shendidi. Peripheral blood and hepatic Toll-like receptor 7 expression and interferon lambda 1 levels in chronic hepatitis C: Relation to virus replication and liver injury. Microbial Pathogenesis 2019; 131: 65 doi: 10.1016/j.micpath.2019.03.032
|
| 19 |
B. Dominguez-Molina, K. Machmach, C. Perales, L. Tarancon-Diez, I. Gallego, J. L. Sheldon, M. Leal, E. Domingo, E. Ruiz-Mateos, Bryan R. G. Williams. Toll-Like Receptor 7 (TLR-7) and TLR-9 Agonists Improve Hepatitis C Virus Replication and Infectivity Inhibition by Plasmacytoid Dendritic Cells. Journal of Virology 2018; 92(23) doi: 10.1128/JVI.01219-18
|
| 20 |
Evangelos Stournaras, Georgios Neokosmidis, Dimitrios Stogiannou, Andreas Protopapas, Konstantinos Tziomalos. Effects of antiviral treatment on the risk of hepatocellular cancer in patients with chronic viral hepatitis. European Journal of Gastroenterology & Hepatology 2018; 30(11): 1277 doi: 10.1097/MEG.0000000000001254
|
| 21 |
Yin Liu, Xia Zou, Wen Chen, Cheng Gong, Li Ling. Hepatitis C Virus Treatment Status and Barriers among Patients in Methadone Maintenance Treatment Clinics in Guangdong Province, China: A Cross-Sectional, Observational Study. International Journal of Environmental Research and Public Health 2019; 16(22): 4436 doi: 10.3390/ijerph16224436
|
| 22 |
Malik Sallam, Rawan Batarseh, Anas Natsheh, Jumana Abbadi, Esraa Al-Fraihat, Alaa’ Yaseen, Doaa Kaddomi, Nadia Khamees, Azmi Mahafzah, Gülşen Özkaya Şahin. An update on hepatitis C virus genotype distribution in Jordan: a 12-year retrospective study from a tertiary care teaching hospital in Amman. BMC Infectious Diseases 2020; 20(1) doi: 10.1186/s12879-019-4735-3
|
| 23 |
Fatemeh Farshadpour, Reza Taherkhani. Antibody-Dependent Enhancement and the Critical Pattern of COVID-19: Possibilities and Considerations. Medical Principles and Practice 2021; 30(5): 422 doi: 10.1159/000516693
|
| 24 |
Arnolfo Petruzziello, Giovanna Loquercio, Rocco Sabatino, Daniel Vasile Balaban, Najeeb Ullah Khan, Mauro Piccirillo, Luis Rodrigo, Lucia di Capua, Annunziata Guzzo, Francesco Labonia, Gerardo Botti. Prevalence of Hepatitis C virus genotypes in nine selected European countries: A systematic review. Journal of Clinical Laboratory Analysis 2019; 33(5) doi: 10.1002/jcla.22876
|
| 25 |
Michael Braude, Dilip T Ratnam, Louise Marsh, Joshua H Abasszade, Anouk T Dev. Hepatitis C virus treatment with glecaprevir and pibrentasvir in patients co-prescribed carbamazepine: Three case reports. World Journal of Gastrointestinal Pharmacology and Therapeutics 2023; 14(4): 33-38 doi: 10.4292/wjgpt.v14.i4.33
Abstract(530) |
Core Tip(529) |
Full Article(HTML)(1317)
|
Full Article with Cover (PDF)-673K(83)
|
Full Article (Word)-106K(45)
|
Audio-1180K(5)
|
Peer-Review Report-194K(53)
|
Answering Reviewers-120K(55)
|
Full Article (PDF)-385K(141)
|
Full Article (XML)-51K(66)
|
Times Cited (0)
|
Total Visits (5266)
|
Open
|
| 26 |
Abel Makija Nlankpe, Precious Kwablah Kwadzokpui, David Adedia, Jacob Nabei Nignan, Patrick Kwasi Owiafe, Mihajlo Jakovljevic. Seroepidemiology of Hepatitis B and C Virus Infections: A Five-Year Retrospective Study among Blood Donors in Saboba District in the Northern Region of Ghana. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/5599705
|
| 27 |
Muriel Lavie, Xavier Hanoulle, Jean Dubuisson. Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing Antibodies. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.00910
|
| 28 |
Somayeh Shokri, Shahab Mahmoudvand, Reza Taherkhani, Fatemeh Farshadpour, Farid Azizi Jalalian. Complexity on modulation of NF‐κB pathways by hepatitis B and C: A double‐edged sword in hepatocarcinogenesis. Journal of Cellular Physiology 2019; 234(9): 14734 doi: 10.1002/jcp.28249
|
| 29 |
A. B. Damola, J. A. Adeniji, A. S. Bakarey. Hepatitis C virus seropositivity and the risk factors for transmission among blood donors in some selected centers in Lagos State, Southwest Nigeria. Journal of Immunoassay and Immunochemistry 2019; 40(5): 528 doi: 10.1080/15321819.2019.1647853
|
| 30 |
Reza Taherkhani, Sakineh Taherkhani, Fatemeh Farshadpour. Dynamics of host immune responses to SARS-CoV-2. World Journal of Clinical Cases 2021; 9(18): 4480-4490 doi: 10.12998/wjcc.v9.i18.4480
|
| 31 |
Meryem Jefferies, Bisma Rauff, Harunor Rashid, Thao Lam, Shafquat Rafiq. Update on global epidemiology of viral hepatitis and preventive strategies. World Journal of Clinical Cases 2018; 6(13): 589-599 doi: 10.12998/wjcc.v6.i13.589
|
| 32 |
Moema S. Santana, Rute Lopes, Isabela H. Peron, Carla R. Cruz, Ana M.M. Gaspar, Paulo I. Costa. Natural Bioactive Compounds as Adjuvant Therapy for Hepatitis C Infection. Current Nutrition & Food Science 2021; 17(5): 458 doi: 10.2174/1573401316999201009152726
|
| 33 |
Mario Frias, Antonio Rivero-Juárez, Pedro López-López, Antonio Rivero. Pharmacogenetics and the Treatment of HIV-/HCV-Coinfected Patients. Pharmacogenomics 2018; 19(12): 979 doi: 10.2217/pgs-2018-0046
|
| 34 |
Yeshimebet Kassa, Yihenew Million, Sirak Biset, Feleke Moges. Hepatitis B and Hepatitis C Viral Infections and Associated Factors Among Prisoners in Northeast Ethiopia. Journal of Blood Medicine 2021; : 561 doi: 10.2147/JBM.S314556
|
| 35 |
Zeeshan Qamar, Faheem Anwar, Raiz Ahmad, Ihteshamul Haq, Mohsina haq, Arbab Muhammad Kashif Khan, Rafiq Hussain, Abd ullah, Zeeshan Shahzad, Ibrar Ahmad, Muhammad Salman Munir Malik, Muhammad Kamran khan, Jawad Khan. Prevalence of Hepatitis C virus and determination of its genotypes in subjects of Tehsil Daggar District Buner, KP, Pakistan. Clinical Epidemiology and Global Health 2021; 12: 100809 doi: 10.1016/j.cegh.2021.100809
|
| 36 |
Shuxiang Li, Jiarui Li, Yunyang Xu, Ze Xiang, Jian Wu. Editorial: Pathogen-host interaction in the development of viral hepatitis. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1333470
|
| 37 |
Yao Wang, Zeyu Zhao, Mingzhai Wang, Mikah Ngwanguong Hannah, Qingqing Hu, Jia Rui, Xingchun Liu, Yuanzhao Zhu, Jingwen Xu, Meng Yang, Jing-An Cui, Yanhua Su, Benhua Zhao, Tianmu Chen. The transmissibility of hepatitis C virus: a modelling study in Xiamen City, China. Epidemiology and Infection 2020; 148 doi: 10.1017/S0950268820002885
|
| 38 |
Emily Nguyen, Sam Trinh, Huy Trinh, Huy Nguyen, Khanh Nguyen, Aivien Do, Brian Levitt, Son Do, My Nguyen, Treta Purohit, Eugenie Shieh, Mindie H. Nguyen. Sustained virologic response rates in patients with chronic hepatitis C genotype 6 treated with ledipasvir+sofosbuvir or sofosbuvir+velpatasvir. Alimentary Pharmacology & Therapeutics 2019; 49(1): 99 doi: 10.1111/apt.15043
|
| 39 |
Yao Wang, Zeyu Zhao, Hao Zhang, Qin Lin, Ning Wang, Mikah Ngwanguong Hannah, Jia Rui, Tianlong Yang, Peihua Li, Siying Mao, Shengnan Lin, Xingchun Liu, Yuanzhao Zhu, Jingwen Xu, Meng Yang, Li Luo, Chan Liu, Zhuoyang Li, Bin Deng, Jiefeng Huang, Weikang Liu, Benhua Zhao, Yanhua Su, Tianmu Chen. Estimating the transmissibility of hepatitis C: A modelling study in Yichang City, China. Journal of Viral Hepatitis 2021; 28(10): 1464 doi: 10.1111/jvh.13582
|
| 40 |
Dongxian Ye, Yuqing Tang, Yuanliang Gu, Harris Haleem, Libo Zhang, Youping Zhang, Chunxia Xu, Jinshun Zhao. Evaluation of the effectiveness of a pilot study of hospital-based hepatitis C epidemic surveillance. Medicine 2019; 98(51): e18334 doi: 10.1097/MD.0000000000018334
|
| 41 |
Mohammed Attieh Alzahrani, Ibrahim Mohammed Almanjahi, Yahia Assiri, Omer Assiri, Hassan Organ, Aasem Alshehri, Mohammed Abdullah AlFahadi, Abdullah Mohammed Alshehri, Mushabbab Saeed Hammad, Khalid Nebrawi, Abdulaziz Saad Alshahrani, Abdullah Mohammed Algarni, Ibrahim Ali Alghamdi, Mohammed Safar Alshahrani, Mohammed Elbagir K Ahmed. Outcome of Direct-Acting Antiviral Drugs on Treatment of Naïve Cirrhotic and Non-cirrhotic HCV Patients in Assir Region, Saudi Arabia: A Retrospective Cohort Study. Nigerian Journal of Basic and Clinical Sciences 2024; 21(3): 190 doi: 10.4103/njbcs.njbcs_93_24
|
| 42 |
Huijun Zhang, Xing-Quan Zhang, Lina S. Huang, Xiong Fang, Mohsin Khan, Yan Xu, Jing An, Robert T. Schooley, Ziwei Huang. Synergistic inhibition of hepatitis C virus infection by a novel microtubule inhibitor in combination with daclatasvir. Biochemistry and Biophysics Reports 2022; 30: 101283 doi: 10.1016/j.bbrep.2022.101283
|
| 43 |
Nadia Marascio, Angela Quirino, Giorgio Settimo Barreca, Luisa Galati, Chiara Costa, Vincenzo Pisani, Maria Mazzitelli, Giovanni Matera, Maria Carla Liberto, Alfredo Focà, Carlo Torti. Discussion on critical points for a tailored therapy to cure hepatitis C virus infection. Clinical and Molecular Hepatology 2019; 25(1): 30 doi: 10.3350/cmh.2018.0061
|
| 44 |
Dongxiao Hao, Li-na Niu. Computational Study on the Wealth Conformations of Hepatitis C Virus Envelope Glycoprotein 2 and Role of Its Glycan Coat. Journal of Chemical Information and Modeling 2024; 64(12): 4811 doi: 10.1021/acs.jcim.4c00521
|
| 45 |
Regan Preston, Michael Christmass, Eric Lim, Shirley McGough, Karen Heslop. Diagnostic Overshadowing of Chronic Hepatitis C in People With Mental Health Conditions Who Inject Drugs: A Scoping Review. International Journal of Mental Health Nursing 2024; 33(6): 1840 doi: 10.1111/inm.13396
|
| 46 |
Kun Wei, Ben-Chun Jiang, Jing-Hui Guan, Dong-Na Zhang, Meng-Xuan Zhang, Jun-Long Wu, Guang-Ze Zhu. Decreased CD4+CD25+CD127dim/−Regulatory T Cells and T Helper 17 Cell Responsiveness to Toll-Like Receptor 2 in Chronic Hepatitis C Patients with Daclatasvir Plus Asunaprevir Therapy. Viral Immunology 2018; 31(8): 559 doi: 10.1089/vim.2018.0055
|
| 47 |
Felice Nava, Alfio Lucchini, Marco Riglietta, Liborio Cammarata, Paola Fasciani, Giovanni Tavanti, Paola Trotta, Lucia Trevisi. Barriers for HCV treatment in Italian Drug Abuse Service: Data from a multicentric observational study (SCUDO Project). MISSION 2020; (54) doi: 10.3280/mis54-2020oa10582
|